Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.


TSXV:TLT - Post by User

Comment by N0taP00pon Jan 21, 2025 8:22am
125 Views
Post# 36412972

RE:RE:RE:RE:For new investors...

RE:RE:RE:RE:For new investors...Very well said, McBullish.  It's either BTD (in Q1) or a significant source of funding that does not rely on dilution to survive another month. Everyone is keenly watching to see how they will communicate. If past history is any indication, they may try to slip in a delay and hope no one notices.  Let's hope for a break from history this time.   BTD in Q1.  Or stable, long-term funding source. Nothing else really matters now. 
McBullish wrote: Bashers will bash, but this is a penny stock. I dont believe there is any kind of coordinated attempt to drive SP lower to assist in accumulation. Nobody is shorting and bashing isnt going to do anything to the SP.

Ive increased my holdings to 200k and will continue to acquire more but Im really hoping we can hit measurable milestones to increase the SP gradually instead or a boom or bust scenario. BTD pushing again isnt necesssarily a bad thing, but why hasnt this been communicated? Funding also continues to concern me. The potential applications seem to be enormous, but its going to require significant funding for trials. 

Anyone have any insight to whats happening with the 100M government grant that was discussed on the last conference call?

IMO our biggest hurdle right now is visibility. A grant or BTD, that results in a bump to Nasdaq, will provide that. 

Again, all just my opinion


<< Previous
Bullboard Posts
Next >>